Endurance Wealth Management, Inc. Beyond Spring Inc. Transaction History

Endurance Wealth Management, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Oct 28, 2021	SELL	$9.26 - $31.31 $277,800 - $939,300	-30,000 Closed	0 $0
Q2 2021 Aug 04, 2021	BUY	$9.37 - $12.12 $140,550 - $181,800	15,000 Added 100.0%	30,000 $313,000
Q1 2021 May 05, 2021	SELL	$10.61 - $15.77 $477,450 - $709,650	-45,000 Reduced 75.0%	15,000 $166,000
Q4 2020 Jan 15, 2021	BUY	$10.21 - $17.31 $612,600 - $1.04 Million	60,000 New	60,000 $732,000

5.44M

30.3K

1.8K

Ticker BYSI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 38,928,900
Market Cap $95.4M
Description
BeyondSpring Inc., a clinical stage biopharmaceutical company, together with its subsidiaries, focuses on the development of cancer therapies. The company's lead asset is the Plinabulin, a selective immune-modulating microtubule-binding agent that has completed Phase III clinical trials for the prevention of chemotherapy-induced neutropenia; and...

Get notified when there are updates to the investment portfolio of Endurance Wealth Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Endurance Wealth Management, Inc. with notifications on news.